Galectin-3 as a Marker for Increased Thrombogenicity in COVID-19

Galectin-3 as a Marker for Increased Thrombogenicity in COVID-19

Galectin-3 is a beta-galactoside-binding lectin involved in inflammation and lung fibrosis and postulated to enhance thrombosis. In COVID-19, it is considered to be a prognostic marker of severity. The aim of this study was to evaluate whether galectin-3 is associated with thrombogenicity in COVID-1...

Full description

Bibliographic Details
Main Authors: Friebel, J. (Author), Ghanbari, E. (Author), Haghikia, A. (Author), Jakobs, K. (Author), Kränkel, N. (Author), Landmesser, U. (Author), Puccini, M. (Author), Rauch, U. (Author), Reinshagen, L. (Author), Schencke, P.-A (Author)
Format: Article
Language:English
Published: MDPI 2023
Subjects:
COVID-19
galectin-3
increased thrombogenicity
platelet activation
Online Access:View Fulltext in Publisher
View in Scopus

Internet

View Fulltext in Publisher
View in Scopus

Similar Items